SESSION XIV: NEXT QUESTIONS

Session Chairs: John DiPersio and Valeria Santini, MD

Next Questions: Acute Lymphoblastic Leukemia | Elias Jabbour, MD | MD Anderson Cancer Center, Houston, Texas, USA
Next Questions: Acute Myeloid Leukemia | Tapan Kadia, MD | MD Anderson Cancer Center, Houston, Texas, USA
Next Questions: Cellular Therapy | Marcela V. Maus, MD, PhD | Massachusetts General Hospital, Boston, Massachusetts, USA
Next Questions: Chronic Lymphocytic Leukemia | Alessandra Ferrajoli, MD | MD Anderson Cancer Center, Houston, Texas, USA
Next Questions: Chronic Myeloid Leukemia | Jorge E. Cortés, MD | University of Alabama, Birmingham, Alabama, USA 
Next Questions: Aggressive B-Cell Lymphoma | Jason R. Westin, MD, MS, FACP, FASCO | MD Anderson Cancer Center, Houston, Texas, USA 
Next Questions: Indolent B-Cell Lymphoma | Brad Kahl, MD | Washington University, St. Louis, Missouri, USA
Next Questions: T-Cell Lymphoma | Mary Jo Lechowicz, MD | Winship Cancer Institute, Atlanta, Georgia, USA 
Next Questions: Mantle Cell Lymphoma | Krish Patel, MD | Sarah Cannon Research Institute, Nashville, Tennessee, USA
Next Questions: Hodgkin Lymphoma | Nancy L. Bartlett, MD | Washington University, St. Louis, Missouri, USA
Next Questions: Multiple Myeloma | Thomas G. Martin, MD | University of California, San Francisco, California, USA
Next Questions: Myelodysplastic Syndromes | Guillermo Garcia-Manero, MD | MD Anderson Cancer Center, Houston, Texas, USA 
Next Questions: Myeloproliferative Neoplasms | Prithviraj Bose, MD | MD Anderson Cancer Center, Houston, Texas, USA 
Closing Remarks | John DiPersio, MD, PhD | President, Society of Hematologic Oncology